Skip to content

Effect of HD-tDCS combined with virtual reality on pain mechanisms of attention regulation in chronic low back pain individuals

Effect of HD-tDCS combined with virtual reality on pain mechanisms of attention regulation in chronic low back pain individuals

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104383
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-06-24
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-specific Chronic low back pain

Interventions

Experimental group:The experimental group received 20 minutes of VR-based training, true HD-tDCS intervention and health education. VR-based training is done with the help of VR immersive games. A 20-
Control group:The control group received 20 minutes of VR-based training, sham HD-tDCS intervention, and health education. VR-based training is done with the help of VR immersive games. The sham HD-tD

Sponsors

The Sixth Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-60 years old; 2.Right hand 3. Low back pain caused by non-specific causes (such as infection, tumor, fracture, arthritis, intervertebral disc herniation, etc.). 4. the pain site is between the lower edge of the thoracic cavity and the inferior gluteal fold; Pain persisting for more than 3 months; Complaints of pain for more than 3 days per week with a VAS of > 3 points for pain intensity; 5. Beck Depression Inventory (BDI) score < 13 points, non-depressive state; 6. Mini Mental Status Examination (MMSE) greater than 24 points; 7. Have normal or corrected normal vision, and have normal color vision.

Exclusion criteria

Exclusion criteria: 1.There are metal and electronic implants; Known history of intracranial tumor/head injury; 2.Ingestion of opioid analgesics (oral >100 mg per day), tetracyclic antidepressants, antivirals, and antipsychotics; Use of narcotic analgesics two weeks prior to testing; 24 hours prior to testing, use of non-narcotic analgesics (e.g., NSAIDs); 3.Females are pregnant or breastfeeding; 4.Severe scalp trauma, extensive or open head trauma, unable to place electrodes; 5.Participated in similar brain stimulation experiments in the past; 6.History of cardiovascular and cerebrovascular diseases, epilepsy, psychiatric disorders, motion sickness, claustrophobia; 7.Patients with depression who have been medically diagnosed as requiring medication, those who have long-term medication habits, and those who have used painkillers within one month before participating in this study; Use of various antidepressants while participating in the study.

Design outcomes

Primary

MeasureTime frame
Functional NIR spectroscopic imaging indicators;

Secondary

MeasureTime frame
Pressure pain threshold;Degree of lumbar dysfunction;Depression;State Trait Anxiety;Pain Catastrophizing;Quality of Life;Visual analogue scoring;

Countries

China

Contacts

Public ContactYuling Wang

The Sixth Affiliated Hospital, Sun Yat-sen University

wangyul@mail.sysu.edu.cn+86 130 5444 5587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026